ClinicalTrials.gg
RecruitingNCT06908213EMRACSIAUpdated Sep 24, 2026

Multicentric Evaluation of Enhanced Recovery After Surgery Protocol in Adolescent Idiopathic Scoliosis Surgery

An interventional study of Posterior vertebral fusion surgery with Enhanced Recovery After Surgery (ERAS) procedure and Posterior vertebral fusion surgery with standard of care procedure in Idiopathic Scoliosis, sponsored by Hospices Civils de Lyon. Recruiting at 11 sites in France. Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
316
Allocation
Randomized
Ages
11 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 57 studies in Scoliosis with a site in France — 18 open to participants now, 20 under way, 1 of them phase 3. Scoliosis · France.

Planned enrollment
2nd of 25
316 · median 60
Started
2026
with 6 others
No phase
24 of 57
11 open now
Primary completion
2030-08
later than 18 of 19 live
Registered
48th of 57
by date
Lead sponsor
2 of 57
Hospices Civils de Lyon

Among the 57 studies in Scoliosis with a site in France, this one is the 2nd largest by planned enrollment of the 25 interventional ones that give a count, is one of 7 that started in 2026, is one of 24 with no phase, reaches primary completion later than 18 of the 19 other live ones, and was the 48th registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 186 are open to participants now.

Browse Scoliosis studies →

Open to participants now

18 of the 57 studies in Scoliosis with a site in France are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 11 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Scoliosis with a site in France, or all of them as a file.
02

Study summary

Adolescent idiopathic scoliosis is a deformation of the spine affecting 2 to 4% of under 18 years old population. This can have severe physical or psychological impact during adulthood. The deformation causes mechanical constraints resulting in early osteoarthritis, which results in adulthood disability.

There is also an impact on the respiratory function in most severe cases of idiopathic scoliosis. Adolescents affected by a scoliosis with an angle of 40° of more undergo a surgery called posterior fusion during adolescence to limit these impacts.

In France, more than 1000 adolescent patients undergo a surgery called posterior spinal fusion for their severe scoliosis.

This aims to straighten the spine by bone grafting all the vertebras included in the scoliosis. Two metal rods are implanted to favour osteosynthesis of the straight spine.

This intervention suffer of a bad image and worries the patients and their parents, as it needs metal implants near the spinal cord.

The worry comes from the most severe complication that may happen exceptionally following this surgery, which is a definitive paraplegia. The scar is quite large and the surgery reduces the mobility of a part of the spine. The intervention produces a quite large haemorrhage, which leads to a diminution in haemoglobin level, resulting in a fatigue during the following weeks.

On the following days, the patient will need a specific protocol of pain management including morphine-based and anti-inflammatory drugs.

This intervention will often require a 5 to 7 days hospitalization with a 1 to 2 month convalescence period at home or in rehabilitation centre.

This intervention is performed on adolescent patients without comorbidities. Moreover, the surgical approach is not profound passing between the para-vertebral muscles with no close large blood vessels or major organs. The pain is caused by correction tensions and the access to the vertebras during the surgery.

Surgical techniques have considerably evolved allowing shorter interventions and to reduce the loss of blood.

The association between morphine-based treatments and grade I analgesics enables an effective pain management.

This intervention appears to perfectly suit to an enhanced recovery after surgery procedure (ERAS).

ERAS is a set of procedure meant to enhance its tolerance and to reduce its morbidity and the hospitalization duration after surgery and the recovery duration.

ERAS is well developed in adult patients undergoing surgery, it is also well described in paediatric patient especially on adolescent scoliosis surgeries.

As the pain is well controlled during the hospitalization as well when the patient get back home, there are very few obstacles to an ERAS procedure in this indication for a patient without comorbidities.

Numerous articles report experiences of medical staff with ERAS protocols.

Generally, the set of measures includes:

  • Before surgery: Providing information and therapeutic patient education, iron supplementation, physiotherapy, skin disinfection, digestive preparation against constipation
  • During surgery: recuperations of blood cells to limit blood loss, use of modern tools to facilitate the positioning of pedicle screws, surgery performed by 2 surgeons
  • After surgery: Pain management until stopping of analgesics by patient and maintenance of a link between the patient at home and the hospital staff after end of hospitalization The articles published about ERAS reports a favourable experience of such protocols with an efficient pain management, reduced hospitalization durations without increasing morbidity or re-hospitalizations. However, no studies have studied and proved by a robust scientific method the benefits of ERAS in adolescent scoliosis.

No studies evaluate the patients' quality of life or follow the patient for more than 6 months after surgery (limiting the assessment of long term complications e.g. infectious complications).

The link between hospital staff and the patient after his return back home is not described as well.

This research project aims to confirm with a robust scientific approach that ERAS protocols in idiopathic scoliosis in adolescents allow to reduce the duration of hospitalization compared to standard of care procedures while improving quality of life after surgery.

03

Conditions studied

  • Idiopathic Scoliosis

Browse trials for

Keywords

  • Idiopathic scoliosis
  • adolescents
  • Enhanced recovery after surgery
04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents between 11 and 17 years old
  • Adolescent idiopathic scoliosis diagnosis
  • Posterior vertebral fusion surgery indicated to treat the patient
  • signed by both parents / legal guardians

Exclusion criteria

Exclusion Criteria:

  • Comorbidities that might influence the duration of hospitalization (e.g. respiratory failure, diabetes…)
  • Previous spine surgery
  • Patient not benefiting from an health insurance plan
  • Pregnant, parturient or breastfeeding woman
  • Patient benefiting of psychiatric care
  • Patient subject to a legal protection measure (guardianship, curatorship)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
316 participants (estimated)

Study arms

  • Experimental
    Experimental group : Improved Recovery After Surgery

    Patients in this group will undergo vertebral posterior fusion surgery with the Enhanced recovery after surgery protocol. This will include at least: * A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents. * A transition to morphine based treatments per os from intravenous morphine on the second day following surgery * Phone calls from a surgery unit nurse 2 times a day during 5 days * A teleconsultation with the surgeon between D3 and D5 following surgery Patients will also have a first consultation with the anesthesist and the surgeon then the surgery will be planned. They will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

    Procedure: Posterior vertebral fusion surgery with Enhanced Recovery After Surgery (ERAS) procedure

  • Experimental
    Control group

    Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS. They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery. Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

    Procedure: Posterior vertebral fusion surgery with standard of care procedure

Interventions

  • ProcedurePosterior vertebral fusion surgery with Enhanced Recovery After Surgery (ERAS) procedure

    This will include at least: * A one-day hospitalization to visit the surgical unit and to provide therapeutic education to patients and their parents. * A transition to morphine based treatments per os from intravenous morphine on the second day following surgery * Phone calls from a surgery unit nurse 2 times a day during 5 days * A teleconsultation with the surgeon between D3 and D5 following surgery

  • ProcedurePosterior vertebral fusion surgery with standard of care procedure

    Patients in this group will undergo posterior vertebral fusion surgery without the set of procedures for ERAS. They will have a first consultation with the anesthesist and the surgeon then the surgery will be planned. The discharge from hospital after surgery will not happen early and the standard of care procedures will be followed during and after surgery. Patients will receive 2 phone calls at D1 and D5 after surgery. The patient will also have 2 appointments at the hospital for post-surgical follow-up at D45 and M12.

06

What researchers measure

Primary outcomes

  1. Demonstrate that ERAS in adolescent idiopathic scoliosis compared to standard of care procedure

    Hospitalization duration measured in days

    Time frame: At Month 3 (Collected on the day of discharge from surgery hospitalization)

Secondary outcomes

  1. Improvement of quality of life at one day after return at home

    Quality of life questionnaires (PedsQL) at day 1 after return at home 4-point scale : 0 if it's never a problem 1. if it's almost never a problem 2. if it's sometimes a problem 3. if it's often a problem 4. if it's almost always a problem

    Time frame: Day 1 (VT1) after discharge from surgery hospitalization

  2. Improvement of quality of life at 5 days, 45 days and 12 months after return at home

    Quality of life questionnaires (PedsQL) at day 5, day 45 and month 12 after return at home 4-point scale : 0 if it's never a problem 1. if it's almost never a problem 2. if it's sometimes a problem 3. if it's often a problem 4. if it's almost always a problem

    Time frame: Day 1 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization

  3. Changing post-surgical pain during hospitalization

    Visual analog pain scale during surgery hospitalization 10-point scale: 0: no pain 10: uncontrollable pain

    Time frame: Day 0 (V3), day 1 (VT1), day 5 (VT3); day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization]

  4. Changing post-surgical pain at day 1, day 5, day 45 and month 12 after return at home

    Visual analog pain scale 10-point scale: 0: no pain 10: uncontrollable pain

    Time frame: Day 1 (VT1), day 5 (VT1), day 45 (V4) and month 12 (V5) after discharge from surgery hospitalization

  5. Changing post-surgical complications at day 45 and month 12

    Complications after surgery at day 45 and month 12 10-point scale: 0: no pain 10: uncontrollable pain

    Time frame: Day 45 (V4) and month 12 (V5)

  6. Changing the rate of re-hospitalization during the 12 months following surgery

    Re-hospitalization rate during the 12 monts following surgery

    Time frame: From day of surgery day 0 (V3) to month 12 (V5)

  7. Describe the acceptability of the early discharge date from hospitalization in the two arms by patients and their parents

    Percentage of parents refusal for early discharge date

    Time frame: Day of surgery day 0 (V3)

07

Study locations

11 of 11 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Aug 2030, 47 months after the start.

Of 223 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 47 months is above that.

Counting every sponsor, half of 233 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2025
First posted
Apr 3, 2025
StartActual
Sep 21, 2026
Primary completionEst.
Aug 21, 2030
CompletionEst.
Aug 21, 2030
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06908213
Responsible party
Sponsor
First posted
Apr 3, 2025
Start date
Sep 21, 2026
Primary completion
Aug 21, 2030 (estimated)
Completion
Aug 21, 2030 (estimated)
Last update
Sep 24, 2026

Study contacts

Vincent CUNIN
Contact
vincent.cunin@chu-lyon.fr
04 27 85 51 32 ext. +33
Meriem El JANI
Contact
meriem.el-jani@chu-lyon.fr
04 27 85 77 25 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion